Dishman Pharma Surges as Subsidiary Succesfully Completes U.S. FDA Inspection

Dishman Pharma’s Switzerland-based subsidiary, Carbogen Amcis AG has successfully completed the U.S. health regulator’s inspection for two sites without any adverse observations.

The subsidiary has received an Establishment Inspection Report for both sites located at Aarau and Neuland, the company said in a Bombay Stock Exchange filling.

Earlier, Dishman Pharma had also received establishment inspection report for its Naroda site after inspection by the U.S. Food and Drug Administration.

Shares rose 5.5 percent to Rs 140.65 at 1:15 pm on the BSE.